| Literature DB >> 35414555 |
Tanya Doherty1,2,3, Catherine Jane Pereira-Kotze2, Silondile Luthuli4, Lyn Haskins4, Gillian Kingston5, Sithembile Dlamini-Nqeketo6, Gilbert Tshitaudzi7, Chistiane Horwood4.
Abstract
OBJECTIVE: To understand the views of public and private sector health professionals on commercial milk formula, to describe their exposure to companies that market commercial milk formula within their workplaces and to describe their awareness of South African (SA) regulations.Entities:
Keywords: community child health; human resource management; nutrition
Mesh:
Year: 2022 PMID: 35414555 PMCID: PMC9006797 DOI: 10.1136/bmjopen-2021-055872
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Status of South Africa’s legal measures aligned with provisions in ‘The Code’
| Categories monitored | Legal provisions | Score | |||||||||||||||
| Scope (out of 20) | BMS products covered up to age 36 (months) | Complementary foods included | Bottles and teats included | 20 | |||||||||||||
| Monitoring and enforcement (out of 10) | Identifies who is responsible for monitoring compliance | Defines sanctions for violations | Requires that monitoring and enforcement should be independent, transparent and free from commercial influence | 8 | |||||||||||||
| Informational/ educational materials (out of 10) | Informational/ educational materials from industry prohibited | The benefits and superiority of breastfeeding | Maternal nutrition and preparation for and maintenance of breast feeding | The negative effect on breast feeding of introducing partial bottle-feeding | The difficulty of reversing the decision not to breastfeed | Proper use of infant formula | Social and financial implications of its use | Health hazards of inappropriate feeding | Health hazards of inappropriate use | Risk of intrinsic contamination of powdered formula | Reference to proprietary products | Pictures or text idealising BMS | 4 | ||||
| Promotion to general public (out of 20) | Advertising | Samples to public | Promotional devices at point of sale | Gifts to pregnant women and mothers | Contact with mothers | 20 | |||||||||||
| Promotion in healthcare facilities (out of 10) | Overall prohibition on use of healthcare facility for promotion | Display of covered products | Display of placards or posters concerning covered products | Distribution of any material provided by a manufacturer or distributor | Use of health facility to host events, contests or campaigns | Use of personnel provided by or paid for by manufacturers and distributors | 10 | ||||||||||
| Engagement with health workers and systems (out of 15) | Overall prohibition of all gifts or incentives to health workers and health systems | Financial or material inducements to promote products within the scope | Fellowships, study tours, research grants, attendance at professional conferences | Fellowships, etc, not prohibited but must be disclosed to the institution | Provision of free or low-cost supplies in any part of the healthcare system | Donations of equipment or services | Donations prohibited only if they refer to a proprietary product | Product samples | Product information restricted to scientific and factual matters | Sponsorship of meetings of health professionals or scientific meetings | 13 | ||||||
| Labelling (out of 15) | Prohibition of nutrition and health claims | The words ‘Important Notice’ | Statement on superiority of breast feeding | Statement on use only on advice of a health worker | Instructions for appropriate preparation | Warning against the health hazards of inappropriate preparation | Warning that powdered formula may contain pathogens | Pictures that may idealise the use of infant formula | Recommended age for introduction of the product | Importance of continued breast feeding for 2+ years | Importance of no complementary foods <6 months | Image/text suggesting use at <6 months | Images/text that undermines or discourages breast feeding or compares to breast milk | Messages that recommend or promote bottle-feeding | Professional endorsements | 12 | |
| Total score | 87/100 | ||||||||||||||||
Green indicates that the provision is included in the national legal measures (R991); red indicates that the provision is not included in R991.
Profile of participants
| Public sector (17) | Private sector (23) | |
| Study site | ||
| 8 | 13 | |
| 9 | 10 | |
| Profession | ||
| 11 | 8 | |
| 1 | 7 | |
| 5 | 3 | |
| 0 | 5 | |
| Gender | ||
| 17 | 21 | |
| 0 | 2 | |
| Place of work | ||
| 5 | 4 | |
| 12 | 12 | |
| 0 | 1 | |
| 0 | 6 |
GP, general practitioner.